Who
Shalabh K. Gupta
CEO
Company insider
Files Form 4 as: CEO, Unicycive Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jul 2021
- Last trade
- 14 May 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 15 Jun 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —762,200 at $0.00 | filing |
| 14 May 2026filed 15 Jun 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —762,200 at $0.00 | filing |
| 14 May 2026filed 21 May 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —762,200 at $0.00 | filing |
| 14 May 2026filed 21 May 2026 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —762,200 at $0.00 | filing |
| 28 Jul 2025filed 30 Jul 2025 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —325,000 at $0.00 | filing |
| 12 Aug 2024filed 14 Aug 2024 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,868 at $0.00 | filing |
| 15 Apr 2024filed 17 Apr 2024 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,319,583 at $0.00 | filing |
| 28 Aug 2023filed 30 Aug 2023 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,684,775 at $0.00 | filing |
| 11 Jul 2023filed 13 Jul 2023 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | $50K50 at $1,000.00 | filing |
| 11 Jul 2023filed 13 Jul 2023 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —79,252 | filing |
| 11 Jul 2023filed 13 Jul 2023 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —72,047 | filing |
| 11 Jul 2023filed 13 Jul 2023 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —115,275 | filing |
| 11 Jul 2023filed 13 Jul 2023 | UNCY Unicycive TherapeuticsBiotechnology | SEC FORM 4 Code M | —104,612 | filing |
| 8 Mar 2023filed 9 Mar 2023 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $50K50 at $1,000.00 | filing |
| 21 Nov 2022filed 23 Nov 2022 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —86,000 at $0.00 | filing |
| 15 Jul 2021filed 26 Jul 2021 | UNCY Unicycive Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —116,279 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.